Prelude Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-157,247
| Closed | -$426K | – | 1830 |
|
|
2018
Q3 | $426K | Buy |
157,247
+71,835
| +84% | +$195K | 0.02% | 370 |
|
|
2018
Q2 | $163K | Buy |
+85,412
| New | +$163K | 0.01% | 629 |
|
|
2017
Q3 | – | Sell |
-2,400
| Closed | -$4K | – | 1840 |
|
|
2017
Q2 | $4K | Sell |
2,400
-51,300
| -96% | -$85.5K | ﹤0.01% | 1363 |
|
|
2017
Q1 | $173K | Sell |
53,700
-800
| -1% | -$2.58K | 0.02% | 574 |
|
|
2016
Q4 | $74K | Buy |
54,500
+40,900
| +301% | +$55.5K | 0.01% | 890 |
|
|
2016
Q3 | $21K | Sell |
13,600
-4,700
| -26% | -$7.26K | ﹤0.01% | 1268 |
|
|
2016
Q2 | $24K | Buy |
18,300
+16,007
| +698% | +$21K | ﹤0.01% | 1172 |
|
|
2016
Q1 | $12K | Sell |
2,293
-2,830
| -55% | -$14.8K | ﹤0.01% | 1082 |
|
|
2015
Q4 | $40K | Buy |
+5,123
| New | +$40K | 0.01% | 1017 |
|
|
2015
Q3 | – | Sell |
-5,400
| Closed | -$59K | – | 1787 |
|
|
2015
Q2 | $59K | Buy |
5,400
+2,200
| +69% | +$24K | 0.01% | 1025 |
|
|
2015
Q1 | $45K | Sell |
3,200
-7,800
| -71% | -$110K | 0.01% | 1293 |
|
|
2014
Q4 | $186K | Buy |
+11,000
| New | +$186K | 0.03% | 629 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2022 |
|
|
2014
Q1 | – | Sell |
-500
| Closed | -$7K | – | 1956 |
|
|
2013
Q4 | $7K | Sell |
500
-500
| -50% | -$7K | ﹤0.01% | 1427 |
|
|
2013
Q3 | $17K | Sell |
1,000
-9,048
| -90% | -$154K | ﹤0.01% | 1109 |
|
|
2013
Q2 | $163K | Buy |
+10,048
| New | +$163K | 0.04% | 423 |
|